Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study.
Ann Rheum Dis
; 82(2): 212-216, 2023 Feb.
Article
en En
| MEDLINE
| ID: mdl-36100350
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Espondilitis Anquilosante
/
Anticuerpos Monoclonales Humanizados
Tipo de estudio:
Clinical_trials
Límite:
Humans
Idioma:
En
Año:
2023
Tipo del documento:
Article